Cargando…
Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients
Measurable residual disease (MRD) is the most powerful independent predictor of risk of relapse and long-term survival in adults and children with acute lymphoblastic leukemia (ALL). For almost all patients with ALL there is a reliable method to evaluate MRD, which can be done using multi-color flow...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713546/ https://www.ncbi.nlm.nih.gov/pubmed/36453516 http://dx.doi.org/10.3324/haematol.2022.280638 |